drugset / Trial / NCT06287905

A Comparative Study of Using Scorpion Antivenom Versus Scorpion Antivenom and Prazosin

NCT06287905

Phase 4 Unknown 80 enrolled Sohag University
RandomizedSequentialSingle-blindTreatment

Summary

Interventional study designed for the evaluation of characters and the outcome of scorpion sting patients will admit to Sohag University Hospitals in 2 randomized groups. The first group will receive scorpion antivenom only whether by the intravenous or the intramuscular route of administration. The second group will receive a combination of prazosin plus scorpion antivenom whether by the intravenous or the intramuscular route of administration. Both groups will receive proper first aid and supportive treatment

Timeline

Start
2023-02-01
Primary completion
2024-07-01
Completion
2024-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Prazosin Unknown 30 ug/kg Oral

Indications

No indication recorded.